Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- VIRO.CO
- Price
- 11.10
- Stock movement up
- +- (0.00%)
- Company name
- ViroGates A/S
- Exchange
- (CO ,
- Currency
- DKK )
- Sector
- Healthcare >Medical Devices
- Market cap
- 103.03M
- Ent value
- 105.28M
- Price/Sales
- 12.71
- Price/Book
- 36.34
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -21.44%
- 1 year return (CAGR)
- -11.20%
- 3 year return (CAGR)
- -39.93%
- 5 year return (CAGR)
- -32.46%
- 10 year return (CAGR)
- -
Last updated: 2026-03-09
DIVIDENDS
VIRO.CO does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 12.71 |
| Price to Book | 36.34 |
| EV to Sales | 12.98 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 9.28M |
| EPS (TTM) | -1.60 |
| FCF per share (TTM) | -0.77 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 8.11M |
| Gross profit (TTM) | 5.45M |
| Operating income (TTM) | -12.52M |
| Net income (TTM) | -12.39M |
| EPS (TTM) | -1.60 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 67.25% |
| Operating margin (TTM) | -154.36% |
| Profit margin (TTM) | -152.77% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 9.12M |
| Net receivables | 1.70M |
| Total current assets | 14.03M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 14.21M |
| Accounts payable | 654.00K |
| Short/Current long term debt | 4.78M |
| Total current liabilities | 7.74M |
| Total liabilities | 11.38M |
| Shareholder's equity | 2.83M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -5.92M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -5.92M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -436.97% |
| Return on Assets | -87.18% |
| Return on Invested Capital | -191.50% |
| Cash Return on Invested Capital | -91.48% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 11.75 |
| Daily high | 11.75 |
| Daily low | 11.05 |
| Daily Volume | 1K |
| All-time high | 238.00 |
| 1y analyst estimate | - |
| Beta | 0.69 |
| EPS (TTM) | -1.60 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| VIRO.CO | S&P500 | |
| Current price drop from All-time high | -95.34% | -0.89% |
| Highest price drop | -97.73% | -56.47% |
| Date of highest drop | 10 Oct 2024 | 9 Mar 2009 |
| Avg drop from high | -61.85% | -10.84% |
| Avg time to new high | 172 days | 12 days |
| Max time to new high | 1184 days | 1805 days |
COMPANY DETAILS
Marketcap
103.03M
Marketcap category
Small-cap
Description
ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic, a proprietary biomarker used in hospital clinics to guide and inform individuals of their health state, and in hospitals to support clinical decisions and identify high-risk patients, as well as used for a range of acute and chronic health issues, such as cardiovascular disease, type 2 diabetes, and cancer. The company's product includes suPARnostic TurbiLatex, a latex particle-enhanced turbidimetric immunoassay that quantitatively determines the soluble urokinase plasminogen activator receptor (suPAR) level in human K2-EDTA- or lithium heparin plasma samples; suPARnostic ELISA that provides fully quantitative results; and suPARnostic Quick Triage kit for use in the point of care situation for early warning and patient triaging that allows clinicians and nurses to obtain a fast patient prognosis for patient disease severity, progression, and outcome. ViroGates A/S was founded in 2000 and is headquartered in Birkerød, Denmark.
Employees
7
Website
Investor relations
-
SEC filings
CEO
Country
Denmark
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
AI‑powered event technology and SaaS company broadens addressable market and increases enterprise pricing to support path toward profitability NEW YORK CITY, NY AND TORONTO, ON / ACCESS Newswire / Mar...
March 5, 2026
Institutional Investor Converts Warrants, Injecting $595,000 to Accelerate Nextech3D.ai's Blockchain Ticketing Rollout and Event Token Ecosystem NEW YORK CITY, NY AND TORONTO, ON / ACCESS Newswire / O...
October 7, 2025
All-cash purchase price of approximately $700,000; Eventdex serves 60+ customers; generated ~$750K in 2024 revenue and ~$500K year-to-date 2025. Combination unifies Map D's floor mapping with Eventdex...
September 30, 2025
New high-margin, pure profit revenue stream for Nextech3D.ai. NEW YORK, NY AND TORONTO, ON / ACCESS Newswire / September 3, 2025 / Nextech3D.ai (OTCQX:NEXCF)(CSE:NTAR)(FSE:EP2), a leading provider of ...
September 3, 2025
It's the ultimate convergence of AI, AR, mobile, and crypto - built for the future of live experiences NEW YORK, NY AND TORONTO, ON / ACCESS Newswire / July 24, 2025 /Nextech3D.ai (OTCQB:NEXCF)(CSE:NT...
July 24, 2025